BAY 43-9006 Inhibition of Oncogenic RET MutantsFrancesca Carlomagno, Massimo Santoro|JNCI Journal of the National Cancer Institute|2006Cited by 471
The Extent of Linkage Disequilibrium in Four Populations with Distinct Demographic HistoriesAlison M. Dunning, Bruce A.J. Ponder, Catherine S. Healey et al.|The American Journal of Human Genetics|2000Cited by 182
Sorafenib Inhibits Imatinib-Resistant KIT and Platelet-Derived Growth Factor Receptor β Gatekeeper MutantsTeresa Guida, Francesca Carlomagno|Clinical Cancer Research|2007Cited by 73
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474Francesca Carlomagno, Massimo Santoro|Endocrine Related Cancer|2008Cited by 40
Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinasesMarialuisa Moccia, Francesca Carlomagno|Scientific Reports|2021Cited by 17